Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
535.27
+19.93 (3.87%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 915 employees as of December 31, 2025. The number of employees increased by 387 or 73.30% compared to the previous year.
Employees
915
Change (1Y)
387
Growth (1Y)
73.30%
Revenue / Employee
$1,403,213
Profits / Employee
-$355,295
Market Cap
12.37B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 915 | 387 | 73.30% |
| Dec 31, 2024 | 528 | 152 | 40.43% |
| Dec 31, 2023 | 376 | 284 | 308.70% |
| Dec 31, 2022 | 92 | 21 | 29.58% |
| Dec 31, 2021 | 71 | 29 | 69.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 1,220 |
| Exelixis | 1,077 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
MDGL News
- 19 hours ago - Madrigal Pharmaceuticals Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 days ago - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 8 days ago - Madrigal upgraded to Outperform from Peer Perform at Wolfe Research - TheFly
- 9 days ago - Madrigal Pharmaceuticals price target lowered to $962 from $964 at Barclays - TheFly
- 11 days ago - Madrigal Pharmaceuticals price target lowered to $543 from $553 at BofA - TheFly
- 12 days ago - Madrigal Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 12 days ago - Madrigal Pharmaceuticals Earnings release: Q2 2026 - Filings